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 Abstract  
Ytterbium-169 is a promising source for future high dose rate (HDR) brachytherapy            
procedures. The lower energy gamma rays emitted by the radionuclide are readily shielded by              
gold foils as experimentally demonstrated using Gafchromic films. The dose from a            
ytterbium-169 source was decreased approximately 30% at 1, 2, and 3 centimeters as a result of                
shielding with 100 microns of gold. This is approximately three times more effective than              
shielding an iridium-192 source, which had a dose reduction of approximately 10% as a result of                
the 100 microns of gold.  
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 1 Introduction 
Since the 1960s, brachytherapy has been used to treat cancer by destroying tumor cells              
with radiation. This is accomplished through one of two procedures: low dose rate (LDR) or high                
dose rate (HDR) brachytherapy. LDR uses multiple seed sources or wires that are permanently              
implanted in a patient, while HDR uses higher energy seeds that are inserted into a patient                
through a catheter for short periods of time over multiple treatments to create a fractionated dose.                
(1) 
While radiation is effective in treating cancer cells, it also is harmful to healthy tissues.               
Radiation is most harmful to tissues comprised of cells that rapidly divide, have long dividing               
lives, and are unspecialized, as stated by the law of Bergonié and Tribondeau. This makes               
radiation therapy an excellent choice in the treatment of cancer due to the fact cancer cells are                 
rapidly dividing and thus highly susceptible to radiation damage. Bone marrow, the liver, and the               
intestines some of the most radiosensitive organs in the body for the same reasons that make                
cancer cells more susceptible to radiation than normal tissues. (2) 
The goal of this Major Qualifying Project is to investigate the use of a lower energy                
source that could be used for HDR brachytherapy and confine the treatment to a specific area by                 
shielding it with gold. By confining the dose to specific damaged areas by applying shielding to                
protect healthy tissues, the greatest dose could be applied to the diseased area while limiting the                
dose applied to the healthy tissue. 
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 1.1 Background 
1.1.1 Radiation Biology 
Radiation is able to kill cells by destroying or damaging the DNA such that the cell is                 
unable to resume normal cell functions or replicate. The inability for a cell to replicate is called                 
clonogenic cell death. Radiation is also damaging to healthy cells as their DNA can be damaged                
beyond repair. Lower doses of radiation lead to less damage to healthy cells, damage can be                
repared by the body’s DNA repair systems. High doses of radiation cause irreparable damage to               
the cell’s DNA or lead to mutations that do not allow the cell to function normally. As stated                  
above, cancer cells tend to be more radiosensitive than healthy cells due to the law of Bergonié                 
and Tribondeau. In most cases, the nucleus of the cell needs to be directly hit by the ionizing                  
radiation in order to damage the DNA and in turn destroy the cell. (2) 
1.1.2 Brachytherapy 
In radiation oncology, there are two ways to administer radiation treatment: external            
beam therapy and brachytherapy. Brachytherapy employs the use of sealed sources implanted in             
the body to treat cancers. It is most commonly used for treating cervical, prostate, breast, and                
skin cancers. Brachytherapy can be used as a stand-alone procedure or in conjunction with other               
cancer treatments such as external beam therapy, chemotherapy, or surgery. (3) 
Surgically removing part of a cancerous tumor is effective in aiding in radiation             
treatments because of the oxygen fixation hypothesis. The outer cells of a tumor are              
appropriately oxygenated while the cells in the center of the mass are often oxygen starved.               
Those cells that are deoxygenated are more radioresistant than the outer cells. This is because in                
hypoxic cells, free radicals that would bond to and damage DNA but then unbind to form a more                  
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 stable bonds. While most damage from radiation is due to direct exposure to the nucleus that                
damages DNA, radiation can also interact with water in cells to form free radicals, which form                
the strongest bonds in the presence of oxygen. Therefore, by surgically shrinking the tumor,              
more of the tumor cells are oxygenated and are more sensitive to the radiation. This is also a                  
reason why there are fractionated doses given in HDR brachytherapy: the time between doses              
allows for the dead outer cells to be removed from the body so that the the inner cells can receive                    
the appropriate amount of oxygen and for healthy cells to repair minor damage. (2) 
1.1.3 Ytterbium-169 
Using ytterbium-169 for HDR brachytherapy is an idea that has existed for over a decade.               
For example, work completed in 2011 showed that ytterbium-169 could be used to satisfy              
clinical standard RTOG-0321 for the treatment of prostate cancer and showed a statistically             
significant reduction to the dose to at risk organs (4). Ytterbium is a good choice for use as a                   
brachytherapy source because the lower energy gamma rays, as seen in the table below, require               
less material for shielding (5). The average gamma energy for ytterbium-169 is 93 keV,              
excluding values less than 10 keV (6). However, the half-life for this radioisotope is only 32                
days, meaning the radioactive ytterbium-169 source would need to be replaced often (6). 
Ytterbium-169’s lower gamma energies make it possible for gold to be used as an              
effective shield. Gold has a Z value of 79, meaning that gold has 79 protons. The heavy nucleus                  
of gold readily absorbs gamma rays, especially at lower energies. Gold is a good choice for a                 
shielding material for brachytherapy because it is a biocompatible substance. While lead is an              
effective shield for gamma emitting radionuclides, it is dangerous for the body. (2) 
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 Table 1: ​Comparison of peak gamma energy values for ytterbium-169 and iridium-192 (7). 
Ytterbium-169 Iridium-192 
Energy (keV) Intensity (%) Energy (keV) Intensity (%) 
63 44.2 308 30.0 
109 17.47 316 82.81 
177 22.16 468 47.83 
197 35.8 604 8.23 
 
1.1.4 Current Brachytherapy Practices and Limitations 
Iridium-192 is the current gold-standard source for HDR brachytherapy. The          
microSelection-HDR iridium-192 source manufactured by Nucletron has a 73.81 day half-life           
and emits high energy gamma rays with an average energy of 370 keV (8). This energy is high                  
enough to give appropriate dose to diseased tissues; however it can also damage the surrounding               
healthy tissues. As a result of the higher energy gammas, iridium-192 is not an ideal source to be                  
shielded with gold to confine the dose to specific areas. Therefore, when working around              
radiosensitive tissues, current practices of brachytherapy are limited by the dose the most             
sensitive tissues near the source can receive.  
1.1.5 Gafchromic Film Dosimetry 
Gafchromic Films were chosen for this investigation because they are tissue equivalent,            
can be submerged in water to meet TG-43 protocol for brachytherapy dose calculation formalism              
as stated by the American Association of Physicists in Medicine, and unlike thermoluminescent             
detectors, do not have an energy dependence for use with ytterbium-169 (9). They can easily be                
cut to size and shape needed for experiments (10). The films are easy to calibrate and can be                  
analyzed with a 16-bit scanner and free image software, ImageJ (11). The red channels of the                
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 scanned films were used for calculating dose because they are the most sensitive to radiation, as                
seen in Figures 4 and 6 (10). 
1.2 Hypothesis 
Because of the lower energy spectrum, ytterbium-169 can be locally shielded in the             
catheter to enable the therapeutic source to be concentrated into the tumor while also lowering               
the dose to nearby healthy tissue. 
1.3 Specific Aims of this Report 
The specific aims of this Major Qualifying Project are to evaluate ytterbium-169 for use              
as an HDR brachytherapy source that can be used to better conform the radiation therapeutic               
dose to the shape of the tumor and limit exposure to nearby healthy tissue. This will be achieved                  
by comparing the change in dose due to 100 microns of gold shielding to the change in dose due                   
to the same shielding for a iridium-192 source. The goal is to experimentally show that dose                
from the source can be reduced with the gold shielding. 
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 2 Methodology 
2.1 Experimental Design 
2.1.1 Design of a Holder for Gafchromic Radiation Dosimetry of Yb-169 and Ir-192 
In order to irradiate the films at equal distances from the source, a holder was designed                
and 3D printed using ABSplus materials. This design includes two base plates with half circle               
divets to fit the the half circle walls that sandwich the film, seen in the upper left of Figure 1. The                     
half circle walls are at every centimeter up to 10 centimeters. The holder is designed such that                 
films will be parallel to the catheter that holds the source.  
Figure 1:​ Final rendering of holder design from SketchUp. 
In the final printed product, holes were drilled on the edge for guide wires to be fed                 
through. These cords were used to hold the film holder in center of the water tank such that the                   
system could be surrounded by at least 30 centimeters of water on each side as dictated by                 
TG-43 protocol (9). The water surrounding the film and source helps to account for scatter. Also,                
water is nearly tissue equivalent, since tissue is comprised of mostly water, so the attenuation               
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 due to tissue is similar to the attenuation of the water (12). The guide wires also provided a place                   
to attach a weight to keep the film holder submerged during the completion of the experiment. 
The center of the bases have a hole so the catheter can be fed through such that one side                   
is attached to the lead pig holding the source and the other is attached to the afterloader. The                  
source tail is fed through the entire length of the catheter so the afterloader can be used to pull                   
the source to the midpoint in the setup, behind gold shielding, electronically. The afterloader              
features a motorized crank that can be programmed to pull the wire source tail a specific                
distance, leave it at the distance for a specific time, then move the source back into the lead pig.                   
This is to limit exposure to the experimentalists. The entire setup is seen below in Figure 2.  
Figure 2:​ Film holder setup submerged in water. Left side shows a view from the side of the tank, while right side 
show the view from the location of the afterloader. 
The catheter was supported by a semi circular sturdy plastic. The gold foil was attached               
to this plastic half tube as seen in Figure 3. The edges of the gold were marked with tape such                    
that finding the proper location for the source could be observed from a distance. 
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 Figure 3:​ Catheter and plastic support with gold shielding with a loaded dummy source. 
2.2 Calibration of Gafchromic Films 
The Gafchromic films darken with increase in dose which correlates to a lower grayscale              
value. In order to convert from grayscale value, which is given by the Plot Profile feature on                 
ImageJ, and intermediate step of converting to optical density is needed (11). The net optical               
density is found from the following equation (13): 
et OD og10( )N = l average grayscale exposed−16
average grayscale unexposed−16 (eq. 1) 
where 16 is true black according to the scanner used. The unexposed and exposed average               
grayscale value is found from the average value from the Plot Profiles from the 5 scans as seen in                   
Figure 4. The equation relating the two should be found using a quadratic least squares fit as                 
stated by TG-43 protocol (9). The dose has a quadratic dependence on net optical density. This                
function of the relationship found by calculating the net optical density of films uniformly              
irradiated to a known dose. In Figure 5 are the calibration scans for this experiment. Note that the                  
film darkens as the dose to the film increases. The net optical densities and their corresponding                
dose for the 15 calibration films are found in Appendix A. 
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Figure 4:​ Plot Profile on ImageJ  for calibration scan (11). Selecting “List” from the Plot Profile window lists the 
grayscale value for each pixel of the line selection. 
 
Figure 5: ​Calibration films.. The films increase in dose as one moves from left to right and top to bottom. 
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 2.3 Film Irradiation 
Prior to irradiation, films were cut to size such that they would fit between the printed                
walls. The exception was the 1 centimeter films, which were cut with overhang for ease of                
bending the film to fit between the two wall pieces. The films were labeled and scanned 5 times                  
each on a 16-bit RGB scanner. The scanned files were saved as .tiff files.  
Films were irradiated to approximately 200 centigray (cGy) as determined by the            
following equation (14): 
.263 0  Σ t
X = 5 × 1 −6 × A i r 2
y E (μ /ϱ) i i en i (eq. 2) 
where A is activity of the source is becquerels, y​i is the yield of photons for energy E​i ​in MeV,                    
(μ​en​/ρ)​i the mass energy coefficient of water for each energy, and r the distance from the source                 
to the detector, in this case the film, in centimeters. Equation 1 gives a solution in terms of                  
Roentgen/hour, this is converted to centigray/hour by multiplying by a factor of 0.96. The time               
was calculated by substituting 200/0.96 Roetgen for X and solve for t. The times that the film                 
were irradiated are located in Table 2. Films irradiated with ytterbium source were exposed for               
longer time periods due to the lower activity of the source as a result of decay. The films were                   
irradiated one at a time due to the different times needed to reach the desired dose. After                 
irradiation, the films were scanned again with the 16-bit RGB scanner 5 times each and saved as                 
.tiff files. This process was repeated for each distance with both sources. 
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 Table 2:​ Irradiation times for films. 
 Ytterbium-169 Iridium-192 
1 cm 1.5 hr 2 min 
2 cm 6 hr 9 min 
3 cm 18 hr 23 min 
2.4 Film Analysis 
As with the calibration scans, the irradiated films were all scanned 5 times before and               
after exposure. The unexposed average was found in the same way as for the calibration scans by                 
drawing a line segment on the red channel of the image, plotting the profile, and finding the                 
average grayscale value from the “List” option on the Plot Profile window. For the exposed               
value, the line was drawn down the middle of the exposed region. Below in Figure 6 is an                  
example of the Plot Profile of Scan 4 of a film irradiated with ytterbium-169 at a distance of 1                   
centimeter. 
The Plot Profile “Save…” feature was used in the film analysis to export the grayscale               
values at their pixel location in the (x,y) coordinates of (pixel of line segment, grayscale value) to                 
an Excel file. These files were then used to calculate and plot dose as a function of their pixel                   
location on the line segment. This was done by creating a table as seen in the example below.                  
Net optical density was calculated following Equation 2 above. Dose was calculated using the              
equation found in Figure 5 replicated here: 
123.2x 72.97x .7729y = 1 2 + 7 − 6 (eq. 3) 
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 where x is net optical density and y is dose in centigray. The graphs of dose from the grayscale                   
values are found in Appendix B. 
When determining the average dose for the shielded and unshielded portions of the film,              
the dose versus pixel graphs were evaluated and the two straightest portions were averaged. See               
Figure 7 below for an example.  
Table 3:​ Example of analysis irradiated films to plot dose as function of pixel. This data is from Scan 1 of the film 
irradiated of ytterbium-169 at a distance of 1 centimeter. 
Pixel Exposed 
Grayscale Value 
Average 
Unexposed 
Grayscale Value  
Net Optical 
Density 
Dose (cGy) 
0 29730.438 43925.0183 0.169586207 156.6147999 
1 29671.76 43925.0183 0.170444669 157.6062317 
2 29605.869 43925.0183 0.171410685 158.723856 
3 29552.303 43925.0183 0.172197593 159.6358121 
4 29493.682 43925.0183 0.173060398 160.637325 
5 29364.861 43925.0183 0.174962476 162.8510953 
6 29302.527 43925.0183 0.175885854 163.9287173 
7 29179.686 43925.0183 0.177711314 166.0647428 
8 29232.346 43925.0183 0.176927828 165.1470457 
9 29045.566 43925.0183 0.179713184 168.4157981 
10 29088.371 43925.0183 0.179073275 167.6632912 
11 29109.064 43925.0183 0.178764265 167.3002373 
12 28819.543 43925.0183 0.183107816 172.4231282 
13 28768.439 43925.0183 0.183879037 173.3371559 
 
 
15 
 Figure 6:​ Plot Profile for film exposed the ytterbium-169 source at a distance of 1 centimeter. The grayscale plot 
has the lowest plateau, between 0 and 10 pixels, where the dose is the highest due to the lack of shielding. The 
higher plateau, between approximately 35 and 45 pixels, is the lower dose where the source was shielded by the 
gold. The trailing values after 45 pixels are a result of missing the exposure that was perpendicular to the source. 
16 
  
Figure 7:​ Graph of dose versus pixel labeled with where the unshielded and shielded regions were. These values 
were averaged for the average dose of the shielded and unshielded areas of this film. This example shows dose for 
iridium-192 at a distance of 1 centimeter.  
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 3 Results and Discussion 
3.1 Calibration Results 
Figure 8 shows the calibration curve used in this research. This was used in the               
calculation of the dose for films irradiated in the experimental portion.  
Figure 8:​ Resulting  calibration curve for the calibration scans. The values used for this plot are found in Appendix 
A.  
3.2 Irradiated Film Results and Discussion 
The following table shows the average dose for the 5 scans for the unshielded and               
shielded regions as demonstrated in Figure 7. The percent difference is computed as seen in the                
following equation: 
18 
 ercent Dif ference 1 ) 00%P = ( − average shielded doseaverage unshielded dose × 1 (eq. 4) 
Table 4:​ Comparison of unshielded and shielded doses for both ytterbium-169 and iridium-192 at distances of 1, 2, 
and 3 centimeters. 
 Yb-169 Ir-192 
Unshielded 
Dose 
(cGy) 
Shielded 
Dose 
(cGy) 
Percent 
Difference 
(%) 
Unshielded 
Dose 
(cGy) 
Shielded 
Dose 
(cGy) 
Percent 
Difference 
(%) 
1cm 171.6 122.0 28.9 155.1 136.5 12.0 
2cm 155.1 100.1 35.5 150.4 136.8 9.0 
3cm 217.7 162.4 25.4 164.0 147.6 10.0 
 
In this table, the change in dose due to the gold shielding is greater at every distance for                  
ytterbium-169. At 1 centimeter, the percent difference is 2.4 times greater for ytterbium-169 than              
for iridium-192. The percent difference for ytterbium-169 is almost 3.9 times greater at 2              
centimeters, the largest gap between the two two sources for the distances tested. At 3               
centimeters, the ytterbium-169 source was shielded 2.5 times more than the iridium-192 source. 
Table 5:​ Standard deviations for the five scans for distances. 
 Yb-169 Ir-192 
Average 
Unshielded 
Dose 
(cGy) 
Standard 
Deviation 
Average 
Shielded 
Dose 
(cGy) 
Standard 
Deviation 
Average 
Unshielded 
Dose 
(cGy) 
Standard 
Deviation 
Average 
Shielded 
Dose 
(cGy) 
Standard 
Deviation 
1cm 171.6 1.06 122.0 3.71 155.1 1.74 136.5 1.95 
2cm 155.1 4.51 100.1 3.39 150.4 0.97 136.8 0.76 
3cm 217.7 2.47 162.4 1.31 164.0 2.12 147.6 2.37 
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 Table 5 above shows the standard deviation for the values of average shield and              
unshielded dose for the 5 scans at each distance. The multiple scans were used to minimize                
variation in the values.  
The following graphs plot both iridium-192 and ytterbium-169 on the same graph. This             
clearly shows the greater change in dose as a result of the 100 microns of gold shielding for                  
ytterbium-169. 
Figure 9:​ Graph comparing the doses of ytterbium-169 and iridium-192 at a distance of 1 centimeter. 
As seen in Table 4, the dose from ytterbium-169 changes almost 30%, while the dose               
from the iridium-192 source changes approximately 12% for the same shielding. This graph             
clearly shows the change as the unshielded dose for ytterbium-169, from approximately pixel 15              
to 20, is greater than the unshielded dose for iridium-192, from approximately pixel 0 to 7, and                 
the shielded dose for ytterbium, approximately pixel 37 to 42, is lower than the shielded dose for                 
iridium, seen from approximately pixel 35 to 40. 
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Figure 10:​ Graph comparing the doses of ytterbium-169 and iridium-192 at a distance of 2 centimeters. 
As with the graph for 1 centimeter, the change in dose a result of the shielding is greater                  
for ytterbium than for iridium. On average, the 2 centimeter films had the greatest separation of                
the percent difference with ytterbium having an average percent difference of 35% and iridium              
having an average percent difference of 9%. 
21 
 Figure 11:​ Graph comparing the doses of ytterbium-169 and iridium-192 at a distance of 3 centimeters. 
The graph for the doses from the source at 3 centimeters is consistent the previous graphs                
for the smaller distances. The ytterbium is shielded approximately 30%, while the iridium is only               
shielded approximately 10%. Scans of the films at 3 centimeters show the greatest difference in               
dose for the unshielded regions for the two sources. The goal was to irradiate the unshielded                
portion to 200 centigray, however this range was rarely met. In this report the comparison of the                 
sources is between the change in dose due to shielding such that the films being irradiated to                 
different doses can still be compared.  
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 4 Conclusions and Future Work 
Based on this data, ytterbium-169 is a feasible choice for conformal brachytherapy            
because 100 microns of gold foil shielding could decrease the dose approximately 30%. This is               
approximate three times greater than change due to shielding for the iridium-192 source. The              
iridium-192 source showed shielding, even with the higher gamma energies. This is because             
there are also lower energy gammas emitted by the iridium source that were absorbed by the gold                 
shielding. Overall, the iridium-192 was shielded less effectively than the ytterbium-169 source. 
The shielding of ytterbium-169 could be used in future brachytherapy treatments by            
conforming the dose to a specific area by shielding areas of healthy tissues. This could be used to                  
craft treatments for cancers near radiosensitive organs such as the retina where the source could               
be shielded to protect the healthy tissue. 
Future iterations of this work could investigate increasing the shielding thickness,           
investigating the shaping of shielding to confine the dose to a target area, and designing shielded                
catheters to house sources in clinical brachytherapy.  
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 6 Appendix A: Table of Calibration Values 
 
Film Number Unexposed 
Average 
Grayscale Value 
Exposed 
Average 
Grayscale Value 
Net Optical 
Density 
Dose (cGy) 
1 43576.45442 43531.16328 0.000451784 0 
2 44750.90758 40981.03238 0.038233242 25 
3 43797.31476 36840.86762 0.075147605 50 
4 43862.21988 35848.1812 0.087658912 75 
5 43431.56228 32702.60714 0.123275587 100 
6 43422.50792 28987.97622 0.175576728 150 
7 43098.9396 26634.41692 0.209123105 200 
8 44285.79608 25808.22624 0.234618692 250 
9 44517.6877 23631.65362 0.275176511 300 
10 43154.45266 20763.30354 0.317902902 350 
11 43765.55536 19534.54286 0.350526251 400 
12 44197.84932 18242.25836 0.384546368 450 
13 43594.79798 17105.77682 0.406538856 500 
14 43889.53436 16210.07736 0.432846412 550 
15 43785.446 14718.35526 0.473784137 600 
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 7 Appendix B: Graphs of Dose for Irradiated Films 
 
Ytterbium-169 at 1cm 
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 Ytterbium-169 at 2 cm 
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Ytterbium-169 at 3cm 
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Iridium-192 at 1cm 
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Iridium-192 at 2cm 
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 Iridium-192 at 3cm 
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